2019 THANZ指南:静脉血栓栓塞的诊断和管理

2019-01-01 澳大利亚和新西兰血栓与止血学会 THANZ官网

2019年1月,澳大利亚和新西兰血栓与止血学会(THANZ)发布了静脉血栓栓塞的诊断和管理指南,静脉血栓栓塞(VTE)包括深静脉血栓形成(DVT)和肺栓塞(PE)是第三大常见的心血管疾病。本文主要诊断VTE的诊断和管理提出专家指导建议,以期指导临床实践。

中文标题:

2019 THANZ指南:静脉血栓栓塞的诊断和管理

英文标题:

The Diagnosis and Management of Venous thromboembolism – Guidelines of the Thrombosis and Haemostasis Society of Australia and New Zealand

发布日期:

2019-01-01

简要介绍:

2019年1月,澳大利亚和新西兰血栓与止血学会(THANZ)发布了静脉血栓栓塞的诊断和管理指南,静脉血栓栓塞(VTE)包括深静脉血栓形成(DVT)和肺栓塞(PE)是第三大常见的心血管疾病。本文主要诊断VTE的诊断和管理提出专家指导建议,以期指导临床实践。 

拓展指南:血栓相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 THANZ指南:静脉血栓栓塞的诊断和管理)] GetToolGuiderByIdResponse(projectId=1, id=70bea1c001e0a54c, title=2019 THANZ指南:静脉血栓栓塞的诊断和管理, enTitle=The Diagnosis and Management of Venous thromboembolism – Guidelines of the Thrombosis and Haemostasis Society of Australia and New Zealand, guiderFrom=THANZ官网, authorId=null, author=, summary=2019年1月,澳大利亚和新西兰血栓与止血学会(THANZ)发布了静脉血栓栓塞的诊断和管理指南,静脉血栓栓塞(VTE)包括深静脉血栓形成(DVT)和肺栓塞(PE)是第三大常见的心血管疾病。本文主要诊断VTE的诊断和管理提出专家指导建议,以期指导临床实践。 , cover=, journalId=null, articlesId=null, associationId=1768, associationName=澳大利亚和新西兰血栓与止血学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Jan 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年1月,澳大利亚和新西兰血栓与止血学会(THANZ)发布了静脉血栓栓塞的诊断和管理指南,静脉血栓栓塞(VTE)包括深静脉血栓形成(DVT)和肺栓塞(PE)是第三大常见的心血管疾病。本文主要诊断VTE的诊断和管理提出专家指导建议,以期指导临床实践。 </div> <div><br> </div>拓展指南:<strong>与<font color="red">血栓</font>相关指南:</strong><br><ul><li><a title="《中国心肺复苏专家共识》之静脉血栓栓塞性CA指南" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=9721f1c00169e128">《中国心肺复苏专家共识》之静脉血栓栓塞性CA指南</a></li> <li><a title="2019 SNIS报告:急性缺血性卒中紧急大血管闭塞血栓切除术的适应证" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=c8e601c00168803b">2019 SNIS报告:急性缺血性卒中紧急大血管闭塞血栓切除术的适应证</a></li> <li><a title="2018 CUA指南:围术期血栓预防和抗凝治疗" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=5a49a1c0016821cc">2018 CUA指南:围术期血栓预防和抗凝治疗</a></li> <li><a title="2018 ESC共识:急性深静脉血栓形成的诊断和管理" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=184251c0016e9169">2018 ESC共识:急性深静脉血栓形成的诊断和管理</a></li> <li><a title="中国血栓性疾病防治指南" target="_blank" href="https://www.medsci.cn/guideline/show_article.do?id=9c6711c0016ea294">中国血栓性疾病防治指南</a></li> 更多信息请点击:<a target="_blank" href="https://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E6%A0%93">有关血栓更多指南</a></ul>, tagList=[TagDto(tagId=3164, tagName=静脉血栓栓塞)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=17439, appHits=781, showAppHits=1, pcHits=7954, showPcHits=10195, likes=146, shares=23, comments=9, approvalStatus=1, publishedTime=Wed Feb 20 21:11:25 CST 2019, publishedTimeString=2019-01-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Feb 20 21:11:25 CST 2019, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 08:21:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 THANZ指南:静脉血栓栓塞的诊断和管理)])
2019 THANZ指南:静脉血栓栓塞的诊断和管理
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2130938, encodeId=21e8213093811, content=有没有中文版哇, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:22 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130937, encodeId=b027213093e27, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:09 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=998177, encodeId=2a7c9981e77e, content=能否翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82d5509267, createdName=ms4000001617073333, createdTime=Sat Jul 10 11:23:05 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953033, encodeId=6b40953033f0, content=<a href='/topic/show?id=d946104218fb' target=_blank style='color:#2F92EE;'>#护体#</a> 啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104218, encryptionId=d946104218fb, topicName=护体)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Thu Apr 01 11:33:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920937, encodeId=607692093efd, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Fri Jan 29 09:52:30 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2023-05-08 ms1000001536868272 来自河南省

    有没有中文版哇

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2130938, encodeId=21e8213093811, content=有没有中文版哇, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:22 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130937, encodeId=b027213093e27, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:09 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=998177, encodeId=2a7c9981e77e, content=能否翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82d5509267, createdName=ms4000001617073333, createdTime=Sat Jul 10 11:23:05 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953033, encodeId=6b40953033f0, content=<a href='/topic/show?id=d946104218fb' target=_blank style='color:#2F92EE;'>#护体#</a> 啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104218, encryptionId=d946104218fb, topicName=护体)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Thu Apr 01 11:33:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920937, encodeId=607692093efd, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Fri Jan 29 09:52:30 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2023-05-08 ms1000001536868272 来自河南省

    有没有中文版

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2130938, encodeId=21e8213093811, content=有没有中文版哇, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:22 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130937, encodeId=b027213093e27, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:09 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=998177, encodeId=2a7c9981e77e, content=能否翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82d5509267, createdName=ms4000001617073333, createdTime=Sat Jul 10 11:23:05 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953033, encodeId=6b40953033f0, content=<a href='/topic/show?id=d946104218fb' target=_blank style='color:#2F92EE;'>#护体#</a> 啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104218, encryptionId=d946104218fb, topicName=护体)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Thu Apr 01 11:33:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920937, encodeId=607692093efd, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Fri Jan 29 09:52:30 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-07-10 ms4000001617073333

    能否翻译成中文

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2130938, encodeId=21e8213093811, content=有没有中文版哇, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:22 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130937, encodeId=b027213093e27, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:09 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=998177, encodeId=2a7c9981e77e, content=能否翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82d5509267, createdName=ms4000001617073333, createdTime=Sat Jul 10 11:23:05 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953033, encodeId=6b40953033f0, content=<a href='/topic/show?id=d946104218fb' target=_blank style='color:#2F92EE;'>#护体#</a> 啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104218, encryptionId=d946104218fb, topicName=护体)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Thu Apr 01 11:33:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920937, encodeId=607692093efd, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Fri Jan 29 09:52:30 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-04-01 站在塔尖

    #护体# 啊啊啊

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2130938, encodeId=21e8213093811, content=有没有中文版哇, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:22 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2130937, encodeId=b027213093e27, content=有没有中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fcf5496473, createdName=ms1000001536868272, createdTime=Mon May 08 10:36:09 CST 2023, time=2023-05-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=998177, encodeId=2a7c9981e77e, content=能否翻译成中文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d82d5509267, createdName=ms4000001617073333, createdTime=Sat Jul 10 11:23:05 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953033, encodeId=6b40953033f0, content=<a href='/topic/show?id=d946104218fb' target=_blank style='color:#2F92EE;'>#护体#</a> 啊啊啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104218, encryptionId=d946104218fb, topicName=护体)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/5924e86cc73c43efb5bad9dd92ac0d7b/63609a5527c447f48b59b39dd248a66f.jpg, createdBy=cf0a5102349, createdName=站在塔尖, createdTime=Thu Apr 01 11:33:31 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920937, encodeId=607692093efd, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210129/bdf7258720c047eaa33e0e2b57d79b93/59ab62b3fd784cc2a9f41efcaf164b23.jpg, createdBy=cac42270752, createdName=121a4306m63暂无昵称, createdTime=Fri Jan 29 09:52:30 CST 2021, time=2021-01-29, status=1, ipAttribution=)]
    2021-01-29 121a4306m63暂无昵称

    受益

    0